Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments.
D000818:Animals; D005260:Female; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D066298:In Vitro Techniques; D008168:Lung / Q000378:metabolism*; D011804:Quinolines / Q000378:metabolism* / Q000494:pharmacology*; D015363:Quinolones; D013189:SRS-A / Q000378:metabolism*
D006634:Histamine H1 Antagonists; D011804:Quinolines; D015363:Quinolones; D013189:SRS-A; C048522:repirinast; C049488:MY 1250